Power Your Lab’s Performance with DxI 9000 Access Immunoassay Analyzer
Every hour, 1 million tests are run on Beckman Coulter analyzers around the world. Discover how Beckman Coulter’s DxI 9000 Access Immunoassay Analyzer drives greater productivity and optimizes your workflow with Doug Lee, North America Marketing Director, Clinical Chemistry and Immunoassay. Learn more about:
- ZeroDaily Maintenance: industry-leading, no daily maintenance required
- PrecisionVision Technology: for real-time error detection & correction
- And more!
The DxI 9000 Analyzer, together with Clinical Chemistry, Automation and clinical IT systems, sets a new standard in performance for today’s busy labs with meaningful innovations that create time for you to focus on what matters most.
Interested in learning more about the DxI 9000 Access Immunoassay Analyzer? Visit now
Ladies and gentlemen, please join us at this historic moment in our industry as Beckman Coulter redefines the standards for immunoassay analyzers.
Let's welcome to the stage, Doug Lee, North America Marketing Director, Clinical Chemistry and Immunoassay.
Thank you. It's great to be here to introduce our latest innovation that reimagines healthcare, the DxI 9000 Access Immunoassay Analyzer. A key principle of how we conduct our business and shape our organization at Beckman Coulter is around the feedback that we get from our customers. When customers talk, we listen, and most importantly, we apply. We understand the staffing shortages that are plaguing laboratories of all sizes, regardless of location, volume, specialty. Our customers are in need of solutions and a partner that can relieve the burden of the laboratory staff.
A few years ago, we launched a suite of standardized and scalable automation solutions with our DxA technology where intelligent automation would be accessible and flexible to fit in laboratories of all sizes. It was not only critical to address the workflow needs of the laboratory, but it was most critical to ensure the highest level of quality, delivery system, and tube characterization on the market, something that exists today. With speed, accuracy, and quality among the top design priorities, we implemented the industry's most comprehensive quality check. In only three seconds, every tube that enters into the laboratory environment undergoes nine unique checks with exclusive patented functionality such as tube type and cap color identification, as well as pre-spun status.
These innovations ensure the highest level of quality and power performance for labs of all sizes, allowing automation for all and was awarded SelectScience Award for the most innovative product in 2020. But we didn't stop there. With the same spirit in design to power your performance and relentless focus on the quality, speed, and accuracy, we're excited to introduce the DxI 9000. The staffing challenges have become difficult in an ever-changing industry, and the quality standards even more rigorous as our physicians, patients, and families expect high quality results without exception. The pressures on the laboratory to perform at the highest level where wasted time, errors, and erroneous results prove costly for your institution and potentially our loved ones.
Now, it's a known statistic that 70% of medical decisions are based on laboratory diagnostic results. And the CDC estimates between 40 to 80,000 deaths occur annually from preventable diagnostic errors. The lab has such a critical role in the care continuum as precise and accurate results are expected to be delivered on time without any exception. And over one million tests per hour are run on Beckman Coulter analyzers across the globe. And like you, we put that burden on ourselves to deliver faster, more precise, and more accurate results, raising the bar not only for ourselves but the entire industry.
The DxI 9000 Access Immunoassay Analyzer sets new expectations in the industry with our immunoassay solutions. Yes, we perform one of the highest throughputs on the market at 450 tests per hour. Yes, we create time for your staff with zero daily maintenance. And yes, we've reduced our assay reaction times by five minutes across every one of our assays. But what I'm most passionate about is how we mitigate risks in laboratory outputs through our quality. Among the many new features of the analyzer, Beckman Coulter's PrecisionVision Technology is unmatched in its ability to inspect, identify, and prevent erroneous reporting in real time. You know more and do more with this patented technology, providing you with confidence in every result.
PrecisionVision Technology is the foundation that allows us to venture into other major challenges we face on a daily basis. Being able to create time by avoiding troubleshooting and rerunning caused from errors and erroneous results, being able to tackle some of the low sample volumes with pediatric and elderly population with some of our assays such as TSH where the aspiration volume was reduced by nearly half. And what's most exciting is being able to expand our menu into novel biomarkers requiring higher sensitivities for precision medicine, helping consolidate instrumentation and manual workstation, offering new insights to drive out unnecessary costs and inefficiency.
Now, I encourage you to take the time to come deep dive with a new DxI 9000 Analyzer during your time here at AACC, and thank you for being with me from wherever you're watching around the world. If you're online, I encourage you to visit us at dxi9000.com. And later, if you're visiting here in Anaheim, please join us in the booth for a number of tours to further uncover the innovations that enable the DxI 9000 Analyzer to create time for your laboratory. Thank you.